PANCREATIC INSUFFICIENCY
Clinical trials for PANCREATIC INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC INSUFFICIENCY trials appear
Sign up with your email to follow new studies for PANCREATIC INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a diabetes drug delay cystic fibrosis-related diabetes?
Disease control Recruiting nowThis study tests whether a weekly injection of dulaglutide (a GLP-1 drug) can improve early insulin release and blood sugar control in adults with cystic fibrosis who have pancreatic insufficiency and abnormal glucose tolerance. About 30 participants will receive the drug or no d…
Matched conditions: PANCREATIC INSUFFICIENCY
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Could a diabetes drug ease blood sugar woes in cystic fibrosis?
Symptom relief Recruiting nowThis study tests a drug called dorzagliatin in 15 adults with cystic fibrosis who have trouble controlling their blood sugar. The goal is to see if the drug improves how the body handles sugar after a meal. Participants will take the drug or a placebo for 7 days each, in a random…
Matched conditions: PANCREATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated May 26, 2026 03:59 UTC
-
Scientists investigate diabetes in cystic fibrosis
Knowledge-focused Recruiting nowThis study looks at why many people with cystic fibrosis develop diabetes. Researchers will test how certain gut hormones (incretins) affect insulin production in the pancreas. The goal is to better understand cystic fibrosis related diabetes and find better ways to treat it. The…
Matched conditions: PANCREATIC INSUFFICIENCY
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated May 26, 2026 04:04 UTC